Management of psychiatric side effects associated with corticosteroids

References

• Brown ES, Suppes T Mood symptoms during corticosteroid therapy: a review. Harvard Rev. PTchiatry5, 239–246 (1998).
   PubMed Web of Science ®Google Scholar
• ••General review of the topic of psychiatricsymptoms with corticosteroids.
   Google Scholar
• Wolkowitz OM. Adrenal steroid disorders in psychiatric practice. American Psychiatric Association Annual Meeting 17A, 64, New York, NY, USA, May (1996).
   Google Scholar
• Brown ES, Khan DA, Nejtek VA. The psychiatric side effects of corticosteroids. Ann. Allergy Asthma Immunol 83,495–503 (1999).
   PubMed Web of Science ®Google Scholar
• •Discusses data on the effects of corticosteroids on mood and cognition.
   Google Scholar
• Wolkowitz OM, Rubinow D, Doran AR et al Prednisone effects on neurochemistry and behavior. Preliminary findings. Arch. Gen. Psychiatry 47, 963–968 (1990).
   PubMedGoogle Scholar
• •Interesting study on the effects of exogenous corticosteroids on healthy controls.
   Google Scholar
• Naber D, Sand P, Heigl B. Psychopathological and neuropsychological effects of 8-days' corticosteroid treatment. A prospective study. PTchoneumendocrinology21, 25–31 (1996).
   Google Scholar
• •Well-designed study examining the effects of corticosteroids on mood and memory.
   Google Scholar
• Brown ES, Suppes T, Khan DA eta]. Mood changes during prednisone bursts in out-patients with asthma. j Gun. PTchopharmacology22, 55–61 (2002).
   Google Scholar
• •Recent study on the mood effects of prescription corticosteroids.
   Google Scholar
• The Boston Collaborative Drug Surveillance Program: Acute adverse reactions to prednisone in relation to dosage. Gun. Pharmacol Ther. 13,694–698 (1972).
   PubMed Web of Science ®Google Scholar
• Varney NR, Alexander B, Macindoe JH. Reversible steroid dementia in patients without steroid psychosis. Am. j Psychiatry 141,369–372 (1984).
   Google Scholar
• Stoudemire A, Anfinson T, Edwards J. Corticosteroid-induced delirium and dependency. Gen. Hosp. Psychiatry 196-202(1996).
   Google Scholar
• Keenan PA, Jacobson MW, Soleymani RM etal The effect on memory of chronic prednisone treatment in patients with systemic disease. Neurology47,1396-1402 (1996). iiNewcomer JW, Craft S, Hershey T et al Glucocorticoid-induced impairment in declarative memory performance in adult humans. j Neurosci. 14,2047-2053 (1994).
   Google Scholar
• Newcomer JW, Selke G, Melson AK etal Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Arch. Gen Psychiatry 56,527–533 (1999).
   PubMed Web of Science ®Google Scholar
• •Excellent study on the effects of corticosteroids on cognition.
   Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disarlers; Fourth Edition, Text Revision OSM-IV-TRTM" American Psychiatric Association, Washington, DC, USA (2000).
   Google Scholar
• Lewis DA, Smith RE. Steroid-induced psychiatric syndromes. j Affect. Disold 5, 319–332 (1983).
   PubMed Web of Science ®Google Scholar
• Bender BG, Lerner JA, Kollasch E. Mood and memory changes in asthmatic children receiving corticosteroids. J. Am. Acad. Child Adolesc. fiychMtry27, 720–725 (1988).
   PubMed Web of Science ®Google Scholar
• Falk WE, Mahnke MW, Poskanzer DC. Lithium prophylaxis of corticotropin-induced psychosis. JAIVIA 241,1011–1012 (1979).
   Google Scholar
• •Only controlled trial of a medication for corticosteroid-induced psychiatric symptoms.
   Google Scholar
• Kemp K, Lion JR, Magram G. Lithium in the treatment of a manic patient with multiple sclerosis: A case report. Dis. Nerv. System38, 210–211 (1977).
   Google Scholar
• Terao T, Yoshimura R, Shiratuchi T eta]. Effects of lithium on steroid-induced depression. Biol. Psychiatry 41,1225–1226 (1997).
   PubMedGoogle Scholar
• Kahn D, Stevenson E, Douglas CJ. Effect of sodium valproate in three patients withorganic brain syndromes. Am. j Psychiatry 145,1010–1011 (1988).
   PubMedGoogle Scholar
• Abbas A, Styra R. Valproate prophylaxis against steroid induced psychosis. Can. j PTchiatry39, 188–189 (1994).
   PubMedGoogle Scholar
• Lynn DJ. Lithium in steroid-induced depression. Br. J. PTchiatry166,264 (1995).
   Google Scholar
• Wada K, Yamada N, Yamauchi Y eta]. Carbamazepine treatment of corticosteroid-induced mood disorder. j Affect. Disord. 65,315–317 (2001).
   PubMedGoogle Scholar
• Meldrum BS. Lamotrigine — a novel approach. Seizure 3(Suppl. A), 41–45 (1994).
   Google Scholar
• Preda A, Fazeli A, McKay BG eta]. Lamotrigine as prophylaxis against steroid-induced mania. j Clin. Psychiatry 60(10), 708–709 (1999).
   Google Scholar
• Brown ES, Fro]. A, Bobadilla L et al Effect of lamotrigine on mood and cognition in patients receiving chronic exogenous corticosteroids. Psychosomatics (In Press).
   Google Scholar
• Ginsberg DL, Sussman N. Gabapentin as prophylaxis against steroid-induced mania. Can. J. PTchiatry 46,455–456 (2001).
   PubMedGoogle Scholar
• Viswanathan R, Glickman L. Clonazepam in the treatment of steroid-induced mania in a patient after renal transplantation. N Engl. J. Med. 320,319–320 (1989).
   PubMedGoogle Scholar
• Blazer DG, Petrie WM, Wilson WP Affective psychosis following renal transplant. Dis. Nerv System 37,663–667 (1976).
   PubMedGoogle Scholar
• Silva RG, Tolstunov L. Steroid-induced psychosis: report of case. j Oral Maxillofac. Surg. 53,183–186 (1995).
   PubMedGoogle Scholar
• Hall RCW, Popkin MK, Stickney RN etal Presentation of the steroid psychosis. j Nerv. Ment. Dis. 167,229–236 (1979).
   PubMed Web of Science ®Google Scholar
• Baloch N. 'Steroid psychosis': a case report. Br. J. fiychiatry124,545–546 (1974).
   PubMed Web of Science ®Google Scholar
• Ahmad M, Rasul FM. Steroid-induced psychosis treated with haloperidol in a patient with active chronic obstructive pulmonary disease. Am. j Emerg. Med. 17, 735 (1999).
   PubMedGoogle Scholar
• DeSilva CC, Nurse MC, Vokey K. Steroid- induced psychosis treated with risperidone. Qn.j fiychiatry47, 388–389 (2002).
   Google Scholar
• Brown ES, Khan DA, Suppes T Treatment of corticosteroid-induced mood changes with olanzapine. Am. j Psychiatry 156,968 (1999).
   PubMedGoogle Scholar
• Wyszynski AA, Wyszynski B. Treatment of depression with fluoxetine in corticosteroid-dependent central nervous system Sjogren's syndrome. Psychosomatics 34,173–177 (1993).
   PubMedGoogle Scholar
• Beshay H, Pumariega AJ. Sertraline treatment of mood disorder associated with prednisone: a case report. J. Chilc Aclolesc. fiychopharmacol 8,187–193 (1998).
   PubMedGoogle Scholar
• Ismail M, Lyster G. Treatment of psychotic depression associated with steroid therapy in Churg-Strauss syndrome. Ir. Med. J. 95, 18–19 (2002).
   PubMedGoogle Scholar
• Hall RC, Popkin MK, Kirkpatrick B. Tricyclic exacerbation of steroid psychosis. Nerv. Ment. Dis. 166,738–742 (1978).
   PubMed Web of Science ®Google Scholar
• Wada K, Yamada N, Suzuki H eta]. Recurrent cases of corticosteroid-induced mood disorder: clinical characteristics and treatment.j Gun. P9rhiatry61, 261–267 (2000).
   Google Scholar
• Brown ES, Chandler PA. Mood and cognitive changes during systemic corticosteroid therapy. Prim. Cale Companion J. Gun. Psychiatry3, 17–21 (2001).
   PubMedGoogle Scholar
• Lewis A, Fleminger JJ. The psychiatric risk from corticotropin and cortisone. Lancet 1, 383–386 (1954).
   Google Scholar
• Lewis DA, Smith RE. Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature. J. Affect. Disold 5,319–332 (1983).
   Google Scholar
• Brown ES, Suppes T Bipolar disorder. In: Psychiatric Clinics of North America Annual of Drug- Therapy Dunner DL, Rosenbaum JF (Eds), WB Saunders Co., Philadelphia, PA, USA, 145–160 (1998).
   Google Scholar
• Bartoszek M, Brenner AM, Szefler SJ. Prednisolone and methylprednisolone kinetics in children receiving anticonvulsant therapy. Gun. Phalmacol Ther 42,424–432 (1987).
   Google Scholar
• Ambrosio AF, Soares-Da-Silva P, Carvalho CM et al Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2–093 and BIA 2–024. Neurochem. Res. 27,121-130 (2002).
   Google Scholar
• Calabrese JR, Bowden CL, Sachs GS etal. A double-blind placebo-controlled study of lamotrigine monotherapy in out-patients with bipolar I depression. Lamictal 602 Study Group. J. Gun. Psychiatry60, 79–88 (1999).
   Google Scholar
• Gilman JT Lamotrigine: an anti-epileptic agent for the treatment of partial seizures. Ann. Pharmacotherapy29, 144–151 (1995).
   PubMedGoogle Scholar
• Ghaemi SN, Gaughan S. Novel anticonvulsants: a new generation of mood stabilizers? Harvatrl Rev. fiychiatry 8,1–7 (2000).
   Google Scholar
• Blanco C, Antia SX, Liebowitz MR. Pharmacotherapy of social anxiety disorder. Biol. P9rhiatry 51,109–120 (2002).
   Google Scholar
• Newcomer JW, Haupt DW, Fucetola R etal Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Atrh. Gen. liychiatry59, 337–345 (2002).
   PubMed Web of Science ®Google Scholar
• Pariante CM, Pearce BD, Pisell TL eta]. Steroid-independent translocation of the glucocorticoid receptor by the antidepressant desipramine. Mal Pharmacol 52,571–581 (1997).
   Google Scholar
• Pepin MC, Pothier F, Barden N. Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression. Mal Pharmacol 42,991–995 (1992).
   Google Scholar
• Sachs GS, Lafer B, Stoll AL eta]. A double- blind trial of bupropion versus desipramine for bipolar depression. J. Clin. Psychiatry 55,391–393 (1994).
   PubMed Web of Science ®Google Scholar
• Brown ES, Dilsaver SC, Shoaib AM eta]. Depressive mania: response of residual depression to bupropion. Biol. Psychiatry 35,493–494 (1994).
   Google Scholar
• Brown ES, Rush AJ, McEwen BS. Hippocampal remodeling and damage by corticosteroids: implications for mood disorders. Neumpsychopharmacology 21 (4), 474–484 (1999).
   PubMedGoogle Scholar
• •Reviews human and animal data on the effects of corticosteroids on the hippocampus.
   Google Scholar